Corrigendum to “Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury” [Neurobiology of Disease Volume 124 (2019) 439–453 /YNBDI_4338]
Titel:
Corrigendum to “Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury” [Neurobiology of Disease Volume 124 (2019) 439–453 /YNBDI_4338]
Auteur:
Bader, Miaad Li, Yazhou Lecca, Daniela Rubovitch, Vardit Tweedie, David Glotfelty, Elliot Rachmany, Lital Kim, Hee Kyung Choi, Ho-Il Hoffer, Barry J. Pick, Chaim G. Greig, Nigel H. Kim, Dong Seok